Literature DB >> 16257871

The association of hypertension and aortic valve sclerosis.

Simon W Rabkin1.   

Abstract

BACKGROUND: Aortic valve sclerosis (AVS), a condition of thickening and calcification of the normal trileaflet aortic valve without the obstruction to left ventricular outflow, is likely the initial stage in the development of aortic stenosis and is associated with an increased incidence of cardiovascular events. The objective of this study is to critically review the data on the association of blood pressure and hypertension with AVS.
METHODS: A systematic search of MEDLINE and EMBASE (to June 2004) was conducted using the keywords hypertension and aortic valve. All English language papers were examined if they dealt with hypertension and AVS. All studies were included for analysis if they had a control group.
RESULTS: Three population-based, cross-sectional studies with a total sample size of 6450 individuals showed a consistent and significant relationship between hypertension and AVS with an odds ratio (OR) ranging from 1.23 to 1.74. Smaller case-control studies with a total sample size of 1609 individuals did not show consistent results but the OR ranged from 1.75 to 2.38. Only one small study (n = 188) showed fewer cases with hypertension and AVS than in the control group. Hypertension was a significant factor remaining in multivariate analysis after consideration of age and other risk factors in several cross-sectional studies. In contrast, other studies with blood pressure measurements consistently showed no increased blood pressures in the presence of AVS. However, these studies did not examine the prevalence of AVS within age-adjusted blood pressure levels.
CONCLUSIONS: Cross-sectional population-based studies present evidence of an association between hypertension and AVS with an OR between 1.23 and 1.74. The major limitation in establishing a causal relationship is the failure to demonstrate a gradient of risk between increasing blood pressure and increasing incidence of AVS. In addition, the literature is confounded by the wide variety of definitions for AVS as well as hypertension. At this time, further data is required to conclude that there is a causal relationship between AVS and elevated blood pressure.

Entities:  

Mesh:

Year:  2005        PMID: 16257871     DOI: 10.1080/08037050500233320

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  10 in total

1.  Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner.

Authors:  Kartik Balachandran; Philippe Sucosky; Hanjoong Jo; Ajit P Yoganathan
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

2.  The effects of combined cyclic stretch and pressure on the aortic valve interstitial cell phenotype.

Authors:  Patrick Thayer; Kartik Balachandran; Swetha Rathan; Choon Hwai Yap; Sivakkumar Arjunon; Hanjoong Jo; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2011-02-23       Impact factor: 3.934

Review 3.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

4.  Experimental measurement of dynamic fluid shear stress on the aortic surface of the aortic valve leaflet.

Authors:  Choon Hwai Yap; Neelakantan Saikrishnan; Gowthami Tamilselvan; Ajit P Yoganathan
Journal:  Biomech Model Mechanobiol       Date:  2011-03-18

5.  Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.

Authors:  Ling Sun; Philippe Sucosky
Journal:  World J Cardiol       Date:  2015-06-26

6.  Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress.

Authors:  Ling Sun; Nalini M Rajamannan; Philippe Sucosky
Journal:  Ann Biomed Eng       Date:  2011-04-01       Impact factor: 3.934

7.  Stages of systemic hypertension and blood pressure as correlates of computed tomography-assessed aortic valve calcium (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Jason Linefsky; Ronit Katz; Matthew Budoff; Jeffrey Probstfield; David Owens; Junichiro Takasu; David Shavelle; Pamela Ouyang; Bruce Psaty; Kevin D O'Brien
Journal:  Am J Cardiol       Date:  2011-01       Impact factor: 2.778

8.  Therapeutic vascular compliance change may cause significant variation in coronary perfusion: a numerical study.

Authors:  S Nobari; R Mongrain; E Gaillard; R Leask; R Cartier
Journal:  Comput Math Methods Med       Date:  2012-03-05       Impact factor: 2.238

9.  Factors associated with aortic valve stenosis in Japanese patients with end-stage kidney disease.

Authors:  Yuji Sasakawa; Naoki Okamoto; Maya Fujii; Jyoichiro Kato; Yukio Yuzawa; Daijo Inaguma
Journal:  BMC Nephrol       Date:  2022-04-02       Impact factor: 2.388

10.  Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.

Authors:  Ling Sun; Nalini M Rajamannan; Philippe Sucosky
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.